These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36316045)

  • 21. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
    Kensler KH; Poole EM; Heng YJ; Collins LC; Glass B; Beck AH; Hazra A; Rosner BA; Eliassen AH; Hankinson SE; Winer EP; Brown M; Tamimi RM
    J Natl Cancer Inst; 2019 Jul; 111(7):700-708. PubMed ID: 30445651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.
    Lin Fde M; Pincerato KM; Bacchi CE; Baracat EC; Carvalho FM
    J Clin Pathol; 2012 Jan; 65(1):64-8. PubMed ID: 22039288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.
    Reeves CV; Dufraine J; Young JA; Kitajewski J
    Oncogene; 2010 Feb; 29(6):789-801. PubMed ID: 19901963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma.
    Kraus TS; Cohen C; Siddiqui MT
    Diagn Pathol; 2010 Sep; 5():63. PubMed ID: 20863373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of androgen receptor in primary breast carcinoma and its relation with clinicopathologic features, estrogen, progesterone, and her-2 receptor status.
    Vellaisamy G; Tirumalae R; Inchara YK
    J Cancer Res Ther; 2019; 15(5):989-993. PubMed ID: 31603099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers.
    Tsang JY; Ni YB; Chan SK; Shao MM; Law BK; Tan PH; Tse GM
    Ann Surg Oncol; 2014 Jul; 21(7):2218-28. PubMed ID: 24639191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.
    Bonkhoff H
    Prostate; 2018 Jan; 78(1):2-10. PubMed ID: 29094395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
    Benitez DA; Pozo-Guisado E; Clementi M; Castellón E; Fernandez-Salguero PM
    Br J Cancer; 2007 May; 96(10):1595-604. PubMed ID: 17486135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.
    Magro G; Bisceglia M; Michal M
    Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lin28A and androgen receptor expression in ER-/Her2+ breast cancer.
    Shen H; Yang Y; Zhao L; Yuan J; Niu Y
    Breast Cancer Res Treat; 2016 Feb; 156(1):135-47. PubMed ID: 26944953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.
    Tokunaga E; Hisamatsu Y; Taketani K; Yamashita N; Akiyoshi S; Okada S; Tanaka K; Saeki H; Oki E; Aishima S; Oda Y; Morita M; Maehara Y
    Cancer Med; 2013 Dec; 2(6):763-73. PubMed ID: 24403250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.
    Greither T; Wedler A; Rot S; Keßler J; Kehlen A; Holzhausen HJ; Bache M; Würl P; Taubert H; Kappler M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29215551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition.
    Sang X; Han H; Li T; Lin SX
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105411. PubMed ID: 31207361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma.
    Fujii R; Hanamura T; Suzuki T; Gohno T; Shibahara Y; Niwa T; Yamaguchi Y; Ohnuki K; Kakugawa Y; Hirakawa H; Ishida T; Sasano H; Ohuchi N; Hayashi S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():513-22. PubMed ID: 25178713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prohibitin promotes androgen receptor activation in ER-positive breast cancer.
    Liu P; Xu Y; Zhang W; Li Y; Tang L; Chen W; Xu J; Sun Q; Guan X
    Cell Cycle; 2017 Apr; 16(8):776-784. PubMed ID: 28272969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.